AMS Capital’s Artivion AORT Stock Holding History

AMS Capital’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-25,157	Closed	-$886K	–	18
2018 Q3	$886K	Buy	+25,157	New	+$811K	0.73%	29

Other funds holding AORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AMS Capital's AORT Position: Q4 2018 in Review

AMS Capital sold out of Artivion (AORT) in Q4 2018, closing a stake of 25,157 shares — an estimated $886K sold.

AMS Capital first reported a position in AORT in Q3 2018 and held it in 1 quarter. The position peaked at $886K in Q3 2018. 144 funds tracked by Wall St. Rank hold AORT as of Q4 2018.

AMS Capital reported no remaining Artivion position as of Q4 2018 after selling out during the quarter.
AMS Capital sold 25,157 Artivion shares in Q4 2018, an estimated $886K.
AMS Capital first reported a position in Artivion in Q3 2018 and held it in 1 quarter.
AMS Capital's Artivion position peaked at $886K in Q3 2018.
144 funds tracked by Wall St. Rank held Artivion as of Q4 2018.

Based on AMS Capital's 13F filing for Q4 2018, filed 29 Jan 2019.